Identification of the erythrocyte receptor for Plasmodium yoelii RhopH complex
约氏疟原虫 RhopH 复合物红细胞受体的鉴定
基本信息
- 批准号:16017272
- 负责人:
- 金额:$ 9.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Parasitophorous vacuole formation is a critical step for the successful invasion of host erythrocytes by malaria parasite. Rhoptry proteins are believed to have essential roles in vacuole formation, although their biological roles are poorly understood. To understand the molecular interactions between parasite rhoptry proteins and the erythrocyte during invasion, we have characterized the binding specificity of the high molecular mass rhoptry protein (RhopH) complex to erythrocytes using the rodent malaria parasite, Plasmodium yoelii and proposed that the major erythrocyte receptor for PyRhopH complex is a protein attached to the erythrocyte surface via GPI-anchor.To further characterize and identify the unknown receptor protein, we employed forward genetic analysis using consomic mouse strains derived from C57BL/6J (B6) and MSM/Ms strains based on the difference in the PyRhopH complex binding to the erythrocytes from these mice (erythrocytes from B6 exhibited higher binding than MSM/Ms). These consomic strains have B6 genetic background and a particular chromosome or chromosomal region is replaced with the one from MSM/Ms. A panel of consomic strains available were examined and the binding among consomic strains were found to be not clearly differentiate to B6 type or MSM/Ms type, indicating that multiple factors were involved in the observed binding. However B6-11^<MSM/Ms>, which harbored chromosome 11 derived from MSM/Ms, showed a prominent low binding, even lower than MSM/Ms, thus we considered that the receptor protein potentially located on chromosome 11. Based on this assumption, we are in a process to narrow the candidate region on the chromosome 11 by further linkage analysis between B6 and B6-11^<MSM/Ms>. The GPI-anchored protein on the candidate region would be characterized as a prime candidate for the PyRhopH complex receptor.
疟原虫空泡的形成是疟原虫成功侵入宿主红细胞的关键步骤。棒状体蛋白被认为在液泡形成中具有重要作用,尽管它们的生物学作用知之甚少。为了了解寄生虫棒状体蛋白和红细胞在入侵过程中的分子相互作用,我们已经使用啮齿类疟原虫表征了高分子量棒状体蛋白(RhopH)复合物与红细胞的结合特异性,约氏疟原虫,并提出PyRhopH复合物的主要红细胞受体是一种通过GPI附着在红细胞表面的蛋白质。锚。为了进一步表征和鉴定未知受体蛋白,我们使用来自C57 BL/6 J(B6)和MSM/Ms品系的同源小鼠品系,基于PyRhopH复合物与这些小鼠的红细胞结合的差异进行正向遗传分析(来自B6的红细胞表现出比MSM/Ms更高的结合)。这些consomic菌株具有B6遗传背景,并且特定的染色体或染色体区域被来自MSM/Ms的染色体或染色体区域所取代。检查了一组可用的consomic菌株,发现consomic菌株之间的结合不能清楚地区分为B6型或MSM/Ms型,表明观察到的结合涉及多种因素。然而,B6-11^<MSM/Ms>,其具有来自MSM/Ms的11号染色体,显示出显著的低结合,甚至低于MSM/Ms,因此我们认为受体蛋白可能位于11号染色体上。基于这一假设,我们正在通过进一步的B6和B6-11^<MSM/Ms>之间的连锁分析来缩小11号染色体上的候选区域。候选区域上的GPI锚定蛋白将被表征为PyRhopH复合物受体的主要候选物。
项目成果
期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
2-Cys peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei
- DOI:10.1016/j.molbiopara.2006.02.018
- 发表时间:2006-07-01
- 期刊:
- 影响因子:1.5
- 作者:Yano, Kazuhiko;Komaki-Yasuda, Kanako;Kawazu, Shin-ichiro
- 通讯作者:Kawazu, Shin-ichiro
Apical expression of three RhopH1/Clag proteins as components of th Plasmodium falciparum RhopH complex
作为恶性疟原虫 RhopH 复合物成分的三种 RhopH1/Clag 蛋白的顶端表达
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Kaneko 0;Yim-Lim BYS;Iriko H;Ling IT;Otsuki H;Grainger M;Tsuboi T;Adams JH;Mattei D;Holder AA;Torii M.;Kaneko O et al.
- 通讯作者:Kaneko O et al.
Nasal immunization with a malaria transmission-blocking vaccine candidate Pfs25 induces complete protective immunity in mice against field-isolated Plasmodium falciparum
使用阻断疟疾传播的候选疫苗 Pfs25 进行鼻免疫可诱导小鼠针对现场隔离的恶性疟原虫产生完全保护性免疫力
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Arakawa T;et. al.
- 通讯作者:et. al.
Apical expression of three RhopHl/Clag proteins as components of the Plasmodium falcioarum RhopH complex.
作为镰状疟原虫 RhopH 复合物成分的三种 RhopH1/Clag 蛋白的顶端表达。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Kaneko 0;Yim-Lim BYS;Iriko H;Ling IT;Otsuki H;Grainger M;Tsuboi T;Adams JH;Mattei D;Holder AA;Torii M.
- 通讯作者:Torii M.
Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro
- DOI:10.1128/iai.72.6.3604-3608.2004
- 发表时间:2004-06-01
- 期刊:
- 影响因子:3.1
- 作者:Preiser, P;Rénia, L;Adams, JH
- 通讯作者:Adams, JH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TORII Motomi其他文献
TORII Motomi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TORII Motomi', 18)}}的其他基金
Development of novel transmission blocking vaccine targeting microgamete surface antigen of Plasmodium falciparum
针对恶性疟原虫小配子表面抗原的新型传播阻断疫苗的开发
- 批准号:
20H03480 - 财政年份:2020
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Assessment of P. vivax transmission-blocking activity of novel vaccine candidate (PvGs24)
新型候选疫苗 (PvGs24) 间日疟原虫传播阻断活性的评估
- 批准号:
16H05816 - 财政年份:2016
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel P. falciparum malaria transmission-blocking vaccine targeted against Pf75
开发针对 Pf75 的新型恶性疟原虫疟疾传播阻断疫苗
- 批准号:
15H04725 - 财政年份:2015
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel malaria transmission blocking vaccine
新型疟疾传播阻断疫苗的开发
- 批准号:
21406010 - 财政年份:2009
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Screening of sporozoite receptor molecule(s) on hepatocytes
肝细胞上子孢子受体分子的筛选
- 批准号:
21390124 - 财政年份:2009
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of erythrocyte proteins interacting with RhopH complex of malaria parasites
鉴定与疟原虫 RhopH 复合物相互作用的红细胞蛋白
- 批准号:
19390120 - 财政年份:2007
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Rosetting of infected erythrocyte and virulence of Vivax malaria
受感染红细胞的玫瑰花结和间日疟疾的毒力
- 批准号:
18406009 - 财政年份:2006
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of the binding domain of Plasmodium falciparum erythrocyte binding protein.
恶性疟原虫红细胞结合蛋白结合域的鉴定。
- 批准号:
16390126 - 财政年份:2004
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of the protein expression level of the erythrocyte binding proteins in Plasmodium falciparum field isolates.
恶性疟原虫野外分离株中红细胞结合蛋白的蛋白表达水平分析。
- 批准号:
15406015 - 财政年份:2003
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structure and functional analysis of high molecule weight rhoptry protein complex, RhopH, of rodent malaria parasite.
啮齿动物疟原虫高分子量棒状体蛋白复合物 RhopH 的结构和功能分析。
- 批准号:
14370084 - 财政年份:2002
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
户外杀蚊真菌农药研制(GC Malaria)
- 批准号:82261128004
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
GC Malaria:研发昆虫不育技术用于控制城市疟疾媒介斯氏按蚊
- 批准号:82261128006
- 批准年份:2022
- 资助金额:130.00 万元
- 项目类别:国际(地区)合作与交流项目
GC Malaria - 利用按蚊天然抗疟共生菌阻断疟疾传播
- 批准号:
- 批准年份:2022
- 资助金额:150 万元
- 项目类别:
GC Malaria:高效实时户外疟疾媒介蚊虫诱捕监测技术和装置的研发
- 批准号:82261128003
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
GC Malaria-基于中药源的媒介生物传染病防控技术及产品开发
- 批准号:82261128005
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
GC malaria:户外诱杀蚊虫的真菌杀虫剂及其释放装置的研发和应用研究
- 批准号:82261128002
- 批准年份:2022
- 资助金额:150.00 万元
- 项目类别:国际(地区)合作与交流项目
相似海外基金
Comprehensive characterization of the genetic factors and the host immune response associated to protection from clinical Plasmodium vivax malaria
与预防临床间日疟原虫疟疾相关的遗传因素和宿主免疫反应的综合特征
- 批准号:
10634775 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Genomics and sero-epidemiology of Plasmodium falciparum malaria in a pre-elimination setting
消灭前环境中恶性疟原虫疟疾的基因组学和血清流行病学
- 批准号:
10666280 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Exocytosis of Plasmodium egress and invasion organelles
疟原虫出口和入侵细胞器的胞吐作用
- 批准号:
10888455 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
- 批准号:
10079676 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
EU-Funded
Extent, dynamics and mechanisms of Plasmodium vivax immune evasion caused by PvDBP gene amplification
PvDBP基因扩增引起间日疟原虫免疫逃避的程度、动态及机制
- 批准号:
10734028 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
- 批准号:
10564073 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling
I 型干扰素信号传导损害抗疟原虫 T 细胞记忆
- 批准号:
10735305 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance
劫持疟原虫泛素蛋白酶体系统以击败耐药性
- 批准号:
10719157 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Elucidating mechanisms for artemisinin-induced dormancy in Plasmodium falciparum
阐明青蒿素诱导恶性疟原虫休眠的机制
- 批准号:
10742385 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Optimising a High Efficacy Plasmodium vivax Malaria Vaccine (OptiViVax)
优化高效间日疟原虫疟疾疫苗 (OptiViVax)
- 批准号:
10077974 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
EU-Funded